RxDoctor Payments Data

Dana Wiley, MD

Psychiatry · Anderson, SCNPI 1427006808

Payments from drug & device makers

$1,031in general payments, 2019–2025

Across 71 payments — averaging $14.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$447
  • Ironshore Pharmaceuticals Inc.$149
  • Otsuka America Pharmaceutical, Inc.$118
  • Johnson & Johnson$82
  • Takeda Pharmaceuticals U.S.A., Inc.$77
  • AbbVie$39
  • plus $119 from 6 others

What the payments were for

  • Food & beverage$1,031100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,031 in reported general payments places this provider in the 65th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$10,884
Medicare patients
29
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide13$6,328
Buprenorphine Hcl12$725
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine31$640
Alprazolam61$378
Buspirone Hcl38$278
Escitalopram Oxalate42$262
Duloxetine Hcl24$244
Aripiprazole22$182
Gabapentin11$157
Donepezil Hcl23$143
Temazepam15$142
Clonazepam21$138
Bupropion XlBupropion Hcl20$129
Methylphenidate Hcl17$119
Pantoprazole Sodium12$98

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$77$6,32813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →